Davide Leone & Partners Investment CO Ltd. Neurocrine Biosciences Inc Transaction History

Davide Leone & Partners Investment CO Ltd.

  • $0
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$89.43 - $102.27 $2.33 Million - $2.67 Million
-26,091 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$87.57 - $119.4 $673,238 - $917,947
7,688 Added 41.78%
26,091 $2.54 Million
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $1.6 Million - $1.99 Million
18,403 New
18,403 $1.76 Million

Others Institutions Holding NBIX

# of Institutions
657
Shares Held
101M
Call Options Held
290K
Put Options Held
214K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Davide Leone & Partners Investment CO Ltd. Portfolio

Follow Davide Leone & Partners Investment CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email